Genomic Subtyping Could Guide Treatment Decisions for Bladder Cancer

Genomic subtyping of muscle-invasive bladder cancer could inform decisions on when best to use neoadjuvant cisplatin-based chemotherapy, according to a retrospective, non-randomized study.

Source: CancerNetwork - February 19, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: ASCO Genitourinary Cancers Symposium Bladder Cancer News Source Type: news